1liboshi H,Ashitani J,Katoh S,et al.Long-term treatment with theophylline reduces neutrophils,interleukin-8 and tumor necrosis factor-alpha in the sputum of patients with chronic obstructive pulmonary disease[].Pulmonary Pharmacology and Therapeutics.2007
2Kroegel C,Foerster M.Phosphodiesterase-4 inhibitors as a novel approach for the treatment of respiratory disease: cilomilast[].Expert Opinion on Investigational Drugs.2007
3Rennard SI,Schachter N,Strek M,et aL.Cilomilast for COPD: results of a 6-month,placebo-controlled study of a potent, selective inhibitor of phosphodiesterase 4[].Chest.2006
4Eguchi Y,Tateishi Y,Umeda N,et al.Effects of Tiotropium or combined therapy with salmeterol on hyperinflation in COPD[].Osaka City Medical Journal.2007
5Bellia V,Foresi A,Bianco S,et al.Efficacy and safety of oxitropium bromide,theophylline and their combination in COPD patients:a double-blind,randomized,multicentre study (BREATH Trial)[].Respiratory Medicine.2002
6Cazzola M,Gabriella Matera M.The additive effect of theophylline on a combination of formoterol and Tiotropium in stable COPD:a pilot study[].Respiratory Medicine.2007
7Dreyse J,Silva F,Diaz O,et al.Clinical and functional benefits of adding theophylline to a standard treatment with short acting bronchodilators in patients with COPD[].Revista Medica de Chile.2005
8O‘Donnell DE,Sciurba F,Celli B,et al.Effect of fluticasone propionate/salmeterol on lung hyperinflation and exercise endurance in COPD[].Chest.2006
9Kardos P,Wencker M,Glaab T,et al.Impact of salmeterol/ fluticasone propionate versus salmeterol on exacerbations in severe chronic obstructive pulmonary disease[].American Journal of Respiratory and Critical Care Medicine.2007
10Calverley PM,Anderson JA,Celli B,et al.Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease[].The New England Journal of Medicine.2007
